LivaNova - LIVN Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LivaNova in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" LIVN shares.
View LIVN analyst ratings or view top-rated stocks.

4 brokerages have issued 12-month price targets for LivaNova's stock. Their LIVN share price forecasts range from $62.00 to $95.00. On average, they expect the company's stock price to reach $76.20 in the next twelve months. This suggests a possible upside of 78.4% from the stock's current price.
View analysts price targets for LIVN or view top-rated stocks among Wall Street analysts.

LivaNova's stock was trading at $55.54 at the beginning of the year. Since then, LIVN stock has decreased by 23.1% and is now trading at $42.71.
View the best growth stocks for 2023 here.

LivaNova saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 1,940,000 shares, a decline of 13.0% from the February 28th total of 2,230,000 shares. Based on an average trading volume of 523,900 shares, the short-interest ratio is presently 3.7 days.
View LivaNova's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our LIVN earnings forecast.

LivaNova will be holding an earnings conference call on Wednesday, May 3rd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

LivaNova PLC (NASDAQ:LIVN) released its quarterly earnings results on Wednesday, February, 22nd. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.09. The business earned $274.90 million during the quarter, compared to analyst estimates of $262.16 million. LivaNova had a negative net margin of 8.44% and a positive trailing twelve-month return on equity of 10.49%. The firm's revenue for the quarter was up 1.8% on a year-over-year basis. During the same quarter last year, the company earned $0.57 earnings per share.

ETFs with the largest weight of LivaNova (NASDAQ:LIVN) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), VanEck Morningstar SMID Moat ETF (SMOT), Simplify Health Care ETF (PINK), Invesco Nasdaq Future Gen 200 ETF (QQQS), Vanguard S&P Mid-Cap 400 Value ETF (IVOV), iShares U.S. Medical Devices ETF (IHI), Vanguard Russell 2000 Growth ETF (VTWG) and Principal U.S. Small-Cap Multi-Factor ETF (PSC).

LivaNova updated its FY23 earnings guidance on Wednesday, February, 22nd. The company provided EPS guidance of $2.45-2.65 for the period, compared to the consensus EPS estimate of $2.48.

47 employees have rated LivaNova Chief Executive Officer Damien McDonald on Glassdoor.com. Damien McDonald has an approval rating of 77% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other LivaNova investors own include BioTelemetry (BEAT), Occidental Petroleum (OXY), Pfizer (PFE), Amarin (AMRN), Genocea Biosciences (GNCA), AbbVie (ABBV), Abbott Laboratories (ABT), ACADIA Pharmaceuticals (ACAD), Chipotle Mexican Grill (CMG) and CRISPR Therapeutics (CRSP).

LivaNova trades on the NASDAQ under the ticker symbol "LIVN."

LivaNova's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Barrow Hanley Mewhinney & Strauss LLC (4.33%), Harris Associates L P (3.75%), Eminence Capital LP (3.25%), Morgan Stanley (3.08%), Dimensional Fund Advisors LP (2.04%) and Victory Capital Management Inc. (2.00%). Insiders that own company stock include Alfred J Novak, Damien Mcdonald, Daniel Jeffrey Moore and Marco Dolci.
View institutional ownership trends.

Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LIVN stock can currently be purchased for approximately $42.71.

LivaNova (NASDAQ:LIVN) has a market capitalization of $2.29 billion and generates $1.02 billion in revenue each year. The company earns $-86,250,000.00 in net income (profit) each year or ($1.62) on an earnings per share basis.

The company employs 2,900 workers across the globe.

LivaNova's mailing address is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. The official website for the company is www.livanova.com. The company can be reached via phone at 442033250660, via email at investor.relations@livanova.com, or via fax at 281-218-9332.